Gafita A, Voter A, Shesadri S, Spitz A, et al. Initial Experience with [(177)Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction. J Nucl Med 2024 Sep 19:jnumed.124.267723. doi: 10.2967/jnumed.124.267723.
PMID: 39299783